Tenth of Ramadan Pharmaceutical Industries & Diagnostic-Rameda (RMDA) Revenue
Revenue
EGP 4.3B
Trailing 12 months (TTM)
As of 23 Jul 2026, 19:29 (Cairo time)
Revenue (also called sales or turnover) is the total income a company generates from its core business before any costs or expenses are deducted. For EGX-listed companies it is reported in the annual income statement in Egyptian pounds.
Revenue history
| Fiscal year | Revenue | YoY growth |
|---|---|---|
| 2025 | 4.1B | 47.94% |
| 2024 | 2.77B | 44.03% |
| 2023 | 1.92B | 29.54% |
| 2022 | 1.48B | 19.06% |
| 2021 | 1.25B | 29.81% |
| 2020 | 960.17M | 7.41% |
| 2019 | 893.97M | 11.02% |
| 2018 | 805.21M | 28.13% |
| 2017 | 628.45M | — |
All monetary figures in EGP. Source: Egyptian Exchange via TradingView; annual figures from company disclosures; updated weekly. Prices refresh every 15 minutes during EGX trading hours.